Engmab competitive analysis

Explore Engmab's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Apr 30, 2026
Patent NumberPublication DateTitleTotal Oppositions
Aug 16, 2023Bispecific Antibodies Against Cd3Epsilon And Bcma For Use In Treatment Of Diseases3

Latest PTAB cases involving Engmab

Discover the latest PTAB cases involving Engmab, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Engmab with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Apr 30, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
ENGMAB - 3 - -
J A KEMP44 - - -
PFIZER53944412
SCORPIO22 - - -